Search clinical trials for: XBD173

Total 4 results

Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder

Anxiety Disorders

United States, Canada
Imperial College London

Not yet recruiting

Endothelial Cell Activation and Total Pulmonary Resistance in PAH

Pulmonary Artery Hypertension
Imperial College London

Withdrawn

Reproducibility of the 11C-PBR28 PET Signal

Neurodegenerative Disorders

United Kingdom
Imperial College London

Recruiting

Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target (TSPO)

Multiple Sclerosis

United Kingdom

3

Subscribe